On a pro rata basis, 80.7% of shares tendered to Roche will be converted to $50 cash, and the remaining 19.3% of tendered shares will be returned to the tendering shareholders:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.